Year: 2026
Type: article
Abstract: AUSTRALIAN life sciences company Medical Ethics has secured European approval for its topical pain relief treatment for use during piglet castration, paving the way for national marketing authorisations in a number of European countries.Steri-Solfen Epilesional Solution for Piglets provides local anaesthesia and antiseptic protection at the surgical wound site.The European Decentralised Procedure was led by the Netherlands as a Reference Member State, with Austria, Belgium, Denmark, Spain, France, Croatia, Italy, Poland and Slovenia supporting the approval.Medical Ethics says its Solfen-Tech platform is the only globally approved topical pain relief and antiseptic technology designed to address acute nociceptive pain associated with castration in piglets.Applied directly to the wound during surgical castration, Steri-Solfen combines two local anaesthetics, lidocaine and bupivacaine, with adrenaline and the antiseptic cetrimide.The formulation is designed to act on the wound at the moment of the procedure, when pain is most intense, and to continue acting for a prolonged period after the procedure is performed, the company says.Medical Ethics was cofounded by Meredith Sheil, a paediatrician and Australian livestock producer who drew on her experience of paediatric pain and medicine to address the lack of effective analgesic options for young livestock.www.medicalethics.me
Source: Veterinary Record
DOI: 10.1002/vetr.71400
Language: English
Subfield: Animal Science and Zoology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W7228486617
